Evidence map›Paper›PMID 32790245›Full record

ReviewPediatric pulmonology2020

Ten key points about COVID-19 in children: The shadows on the wall.

Luis Escosa-García, David Aguilera-Alonso, Cristina Calvo, María José Mellado, Fernando Baquero-Artigao

Abstract readReview
In one paragraph

Review in Pediatric pulmonology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Pediatric endocarditis - a stone left after the pandemic cascade.Frontiers in cellular and infection microbiology · 2024
    Review
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Mortality in children with positive SARS-CoV-2 polymerase chain reaction test: Lessons learned from a tertiary referral hospital in Indonesia.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Luis Escosa-GarcíaDepartment of Pediatrics, Infectious, and Tropical Diseases, La Paz Hospital, The Translational Research Network of Pediatric Infectious Diseases (RITIP), Madrid, Spain.
David Aguilera-AlonsoDepartment of Pediatrics, Pediatric Infectious Diseases Unit, Gregorio Marañón Hospital, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), The Translational Research Network of Pediatric Infectious Diseases (RITIP), Madrid, Spain.ORCID http://orcid.org/0000-0003-1017-2386
Cristina CalvoDepartment of Pediatrics, Infectious, and Tropical Diseases, La Paz Hospital, The Translational Research Network of Pediatric Infectious Diseases (RITIP), Madrid, Spain.ORCID https://orcid.org/0000-0002-6503-3423
María José MelladoDepartment of Pediatrics, Infectious, and Tropical Diseases, La Paz Hospital, The Translational Research Network of Pediatric Infectious Diseases (RITIP), Madrid, Spain.
Fernando Baquero-ArtigaoDepartment of Pediatrics, Infectious, and Tropical Diseases, La Paz Hospital, The Translational Research Network of Pediatric Infectious Diseases (RITIP), Madrid, Spain.ORCID https://orcid.org/0000-0002-6903-3826

Funding

Instituto de Salud Carlos III Contrato Río Hortega CM18/00100
6 · The paper itself

Abstract

The pandemic of the new coronavirus disease-2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), initially described in China, is challenging the health care systems of all countries. Every emerging disease raises many questions with a scarcity of answers since all its characteristics are still being discovered. In the case of SARS-CoV-2, most of the literature comes from adult patients. Children seem to be less affected. Pediatric patients diagnosed with COVID-19 disease usually suffer a mild illness, with a low risk of complications, or mortality. Defining the role of children in the transmission of SARS-CoV-2 is critical as some national infection control decisions involving children, such as school closures or social distancing, will probably impact the dynamics of the virus. To aid in the knowledge of COVID-19 in children, this study presents an expert review of the literature published from 1 January to 28 May 2020, including peer-reviewed and preprint nonpeer-reviewed studies, along with some relevant articles afterward, summarizing ten key points that characterize the disease in children.

Indexed as

COVID-19SARS-CoV-2ChildCoinfectionComorbidityCritical IllnessHumanschildrenCOVID-19epidemiologynovel coronavirusSARS-CoV-2

Identifiers

PMID32790245
PMCPMC7436376

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.